Searchable abstracts of presentations at key conferences in endocrinology

ea0031p202 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Vitamin D and insulin resistance: no association in healthy overweight people at high risk of cardiovascular disease

Wallace Ian , McEvoy Claire , Hamill Lesley , Ennis Cieran , Bell Patrick , Hunter Steven , Woodside Jayne , Young Ian , McKinley Michelle

Observational studies suggest reduced vitamin D levels are associated with an increased incidence of type 2 diabetes mellitus. We examined the relationship with insulin resistance (assessed using a two-step euglycaemic hyperinsulinaemic clamp technique) in 92 overweight, non-diabetic individuals with no history of cardiovascular disease - mean age 56 years (range 40–77 years), 64% males, 36% females, BMI 30.9 kg/m2 (range 26.4–36.9 kg/m2), fasti...

ea0028p166 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Association between low concentration of serum sex hormone binding globulin and insulin resistance is independent of adiposity, but may be attributable to fasting insulin concentration

Wallace Ian , McEvoy Claire , Hamill Lesley , Woodside Jayne , Ennis Cieran , Bell Patrick , Young Ian , McKinley Michelle , Hunter Steven

Introduction: Recently low circulating levels of sex hormone binding globulin (SHBG) have been shown to be a strong predictor of the risk of developing type 2 diabetes. Genetic studies suggest that this may be a primary causal abnormality and the mechanism may relate to effects on insulin resistance.Methods: Insulin resistance was assessed using a two-step euglycaemic hyperinsulinaemic clamp (EHC) in 87 (59 male and 28 post-menopausal female) overweight ...

ea0021p295 | Pituitary | SFEBES2009

Effects on insulin action of dehydroepiandrosterone sulphate replacement in hypopituitary females

McHenry Claire , Bell Patrick , Hunter Steven , Thompson Christopher , Courtney Hamish , Ennis Cieran , Sheridan Brian , McCance David , Mullan Karen , Atkinson Brew

Hypopituitary patients are at increased vascular risk. This may be partly attributable to changes in insulin action. It has been suggested that the addition of dehydroepiandrosterone sulphate (DHEAS), which is low in patients with secondary hypoadrenalism, to routine replacement may have beneficial effects on glucose metabolism. Previously, patient populations and techniques used to assess insulin action varied and overall results have been conflicting.W...